Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Lens, contact, orthokeratology, overnight

Número de PMA: P050031 · 2022-05-10

SolicitanteCooperVision, Inc.
Fecha de decisión2022-05-10
Número PMAP050031
Código de productoNUU
Clase del dispositivoClase 3
Especialidad médicaO
Número de regulación21 CFR 8
Comité asesorOP

Resumen del dispositivo

Lens, contact, orthokeratology, overnight is the device name listed in this FDA 510(k) record. The listed applicant is CooperVision, Inc.. It received FDA 510(k) clearance on 2022-05-10. The device is classified under product code NUU. It was reviewed by the OP advisory panel.

Preguntas frecuentes

What is the Lens, contact, orthokeratology, overnight?

Lens, contact, orthokeratology, overnight is a medical device that received FDA 510(k) clearance on 2022-05-10. The listed applicant is CooperVision, Inc..

When did Lens, contact, orthokeratology, overnight receive FDA 510(k) clearance?

The clearance date for Lens, contact, orthokeratology, overnight can be found in the official FDA records.

Who is the listed applicant for Lens, contact, orthokeratology, overnight?

The FDA 510(k) record lists CooperVision, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lens, contact, orthokeratology, overnight?

The FDA product code for Lens, contact, orthokeratology, overnight is NUU.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑